Enterprise of Rosatom State Corporation
Print version

Industry news


Molecular Imaging Device Market Expected to Rise to $3B by 2018

The current global market for molecular imaging technology is estimated at $2.2 billion this year and is expected to increase at a compound annual growth rate of 6.2 percent, according to a November 2013 market research report from BCC Research.

There is a number of drivers in the market, most notably an uptick in PET and SPECT standalone and hybrid scanner sales. An aging population and increased prevalence of cancer and Alzheimer's disease were also noted as contributing factors in the growing demand for molecular imaging. Nanobiotechnology and robotics appear to be trends gaining momentum in molecular imaging instrumentation, as well as new technologies aimed to meet the demand of molybdenum-99, and in turn technetium used in a majority of nuclear medicine exams, as aging reactors are decommissioned and threaten a shortfall. Potential shortage of technetium is also boosting research and development of alternative imaging agents for SPECT.

For more information visit www.molecularimaging.net


comments powered by Disqus